HC Wainwright Reaffirms Buy Rating for Ocular Therapeutix (NASDAQ:OCUL)
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $15.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 87.27% from the stock’s previous close. A number […]
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $15.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target indicates a potential upside of 87.27% from the stock’s previous close. A number […]
